Flex Vascular
PrivateLast Round
Series C
Oct 29, 2025
Total Funding Raised
$51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Flex Vascular is a medical device company that develops and markets endovascular medical devices for the treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flex Vascular Comparables
Compare Flex Vascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cagent Vascular | 91% | |
| Cardio Flow, Inc. | 82% | |
| Stryker Corporation | 79% |
Flex Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 29, 2025 | ||||
| Convertible Debt | Feb 12, 2025 | ||||
| Convertible Debt | Jan 31, 2023 | ||||
| Convertible Debt | Nov 23, 2021 | ||||
| Series B | Aug 15, 2017 | ||||
Series A | Dec 1, 2014 |
Key People
Founding team and executive leadership
Flex Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RiverVest Venture Partners | Convertible Debt, Series B |
| Endeavour Vision | Convertible Debt, Series C, Series B |
| S3 Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Bruce Fiedler appointed as Chief Financial Officer.
- Oct 29, 2025
$28M round completed.
Flex Vascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Flex Vascular's valuation, stock price, and market status.
Is VentureMed Group a public or private company?
VentureMed Group is a private company.
What is the current stock price of VentureMed Group?
VentureMed Group is a private company with no public stock price. No recent secondary market data is available.
How much is VentureMed Group worth (valuation)?
Valuation information for VentureMed Group is not publicly available.
Can I buy VentureMed Group stock?
VentureMed Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VentureMed Group's last funding round?
VentureMed Group's most recent funding round was Series C on October 29, 2025.
Who are the main investors in VentureMed Group?
Key investors in VentureMed Group include RiverVest Venture Partners, Endeavour Vision, S3 Ventures.
Will VentureMed Group IPO soon?
No public IPO plans have been announced for VentureMed Group.
How can I track VentureMed Group secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VentureMed Group's secondary market activity and sign up for updates.